Momentum Clinical Research

19/11/2025

Today we join the global community in recognising World COPD Day, led by the Global Initiative for Chronic Obstructive Lung Disease - GOLD in partnership with health professionals and patient groups worldwide.

This year’s theme, “Short of Breath, Think COPD,” highlights an important truth:
👉 COPD is the 3rd leading cause of death worldwide, yet it often goes undiagnosed or misdiagnosed.
👉 Early diagnosis can significantly improve symptoms, lung function, and overall quality of life.

COPD may be under-recognised, but it is preventable and treatable. A diagnosis should be considered in people with:
🌬 Shortness of breath
🌬 Chronic cough or sputum
🌬 Frequent chest infections
🌬 Exposure to smoke, cooking fuels, or workplace hazards

At Momentum Clinical Research, we are committed to advancing research that helps improve diagnosis, treatment, and future care options for people living with chronic respiratory conditions.
Let’s raise awareness, encourage earlier detection, and support those affected.

Together we can reduce the burden of COPD. One conversation, one diagnosis, one study at a time.
📅 World COPD Day | November 19

18/09/2025

✨ Why clinical research matters – and how you can be part of it

At Momentum Clinical Research, everything we do starts with people like you.

This is Bruno’s story. He took part in a clinical trial with us and found it not only helped him personally, but also gave him the satisfaction of knowing he was contributing to something bigger – helping bring a new medication to others who need it.

Every clinical trial relies on participants who are willing to take part. Your involvement has the power to move medicine forward, to create options for people who don’t yet have them, and to make a real difference in the lives of others.

If you’ve ever wondered what it’s like to be part of a clinical trial, or how you can help advance future medicines, stories like Bruno’s show just how impactful your involvement can be.

Together, we’re shaping the future of healthcare.

www.momentumclinicalresearch.com/clinical-trials/

17/06/2024

AusTrials has united with Holdsworth House and New Zealand's renowned P3 Research to form Momentum Clinical Research.

AusTrials name will change to Momentum Clinical Research from the 1st of July 2024.

What does this mean for our Participants?
Our Momentum network of 13 sites across New Zealand and Australia enables us to bring more research studies to the region and help accelerate the development of new medicines that are needed by our communities.

Our Mission: To deliver people-centered research and clinical excellence at scale, making meaningful, positive impact in people's lives.

Our promise to you:
We will continue to provide the same local expertise, care and ethical processes but with support from a wider Australasian network.

Rest assured, our name may be changing but our studies will continue to follow the same ethical processes and deliver the same exceptional care by our local experts.

If you are currently enrolled in a study with AusTrials, there will be no change to your clinic visits, contacts or the design of the study you are involved in. If you do have any questions, please contact your study coordinator.

We are excited to begin this new chapter alongside the partners and participants that we have worked with over the past 20 years.

Learn more about Momentum Clinical Research here. www.momentumclinicalresearch.com

See less

15/06/2024

Do you have asthma or diabetes? Get the RSV Vaccine and be a part of this trial. We still need 18-49 year olds for Cohort 3 - no blood collection needed.

  Respiratory Syncytial Virus (RSV) is highly contagious and usually presents like a common cold. However, it can also cause more

06/06/2024

Respiratory Syncytial Virus (RSV) is highly contagious and usually presents like a common cold. However, it can also cause more serious respiratory illness and can lead to complications such as pneumonia. In severe cases, it can be fatal.

Here at AusTrials, we are running a clinical study testing a new vaccine which may prevent RSV infection in adults 18-49 suffering from a chronic illness.

The study involves visits to our dedicated research facilities, along with scheduled telephone contacts. Eligible participants will receive vaccinations free of charge and will be reimbursed for their time and travel.

If you are aged 18-49 and suffer from a chronic illness, please register your interest in participating in this important study by clicking the link below:
https://austrials.com.au/events/respiratory-syncytial-virus-rsv-vaccine-2/

20/05/2024

Today at AusTrials we celebrate the scientists, researchers, healthcare professionals and participants who make clinical trials and medical advancement possible.

Clinical trials have come a long way since 1774 when James Lind, a ship's surgeon in the British Royal Navy started what is often considered to be the first randomized clinical trial. Lind found a cure for scurvy after carrying out a clinical trial in just 12 people, of whom two received the active treatment of citrus fruit to treat the disease caused by vitamin C deficiency.

Here at AusTrials, we take the opportunity to pause and reflect on all that has been accomplished thanks to clinical trials the people behind them.

Happy International Clinical Trials Day from AusTrials!

10/05/2024

Here at AusTrials, we are running a clinical study testing a new vaccine which may prevent RSV infection in adults suffering from chronic illnesses or in adults 60 years of age or older.

  Respiratory Syncytial Virus (RSV) is highly contagious and usually presents like a common cold. However, it can also cause more

09/04/2024

Irritable Bowel Syndrome (IBS) is a common disorder affecting the digestive system.

Here at AusTrials, we are evaluating a new treatment intended to reduce symptoms associated with IBS.

Click the link below for more information and to register your interest.

  Irritable Bowel Syndrome (IBS) is a common disorder affecting the digestive system. Around one in five Australians experience the unpleasant